Spero - SPRO Net Assets per Single Share

Graphic logo of Spero Therapeutics (SPRO)

Spero Therapeutics (SPRO) is developing a pipeline of treatments for severe lung and kidney pathologies, as confirmed by the reported book value per share on the current GURU.Markets chart, where the 0.76 metric reflects the current trend. The company is optimizing expenses by focusing on bringing antibiotics to market through alliances with industry behemoths. Its scientific approach and R&D support help attract leading infectious disease specialists.

Spero Therapeutics Inc (SPRO): Share Book Value from 07/04/2022 to 10/27/2026

sperotherapeutics.com - analytical breakdowns and key metrics (SPRO)

- price and consensus price forecast:
Price Chart Spero|SPRO - Fair Value Consensus
- market capitalization data:
Market Value Spero Therapeutics, Inc.|SPRO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Spero Therapeutics|SPRO - Net Asset Value|Market Capitalization to Book Value Ratio sperotherapeutics.com|SPRO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Spero Therapeutics|SPRO - Long-Term Debt to Capital|Short-Term Debt to Equity Spero Therapeutics, Inc.|SPRO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Spero Therapeutics, Inc.
Fundamental company valuation:Spero - SPRO
Manufactured products of Spero Therapeutics, Inc.

This metric reflects the residual value of net assets allocated per share, allowing for the real-time tracking of the business's intrinsic value between quarterly reports. The growth in total book value per share confirms the financial stability of Spero Therapeutics (SPRO), particularly upon the receipt of payments from GSK and government subsidies, which increase capital without diluting the stakes of current shareholders.

Competitors of Spero Therapeutics (SPRO)

Net Assets per Single Share Summit Therapeutics Inc (SMMT)|MRNA: Accounting Value of a Share|Net Assets per Single Share PCVX|TARS (tarsusrx.com) - Net Asset Value per Share|Net Assets per Single Share CorMedix CRMD|Share Book Value Seres Therapeutics Inc.|SCYNEXIS, Inc. (SCYX) - Book Value per Share|Accounting Value of a Share an2therapeutics.com (ANTX)|Book Value per Share PYPD (PolyPid)|ysbiopharm.com - Book Value per Share|Net Assets per Single Share Iterum Therapeutics, plc (ITRM)|PHGE: Accounting Value of a Share|SNGX (soligenix.com) - Net Assets per Single Share|60 Degrees Pharmaceuticals, Inc. (SXTP) - Accounting Value per Share|OGEN (Oragenics) - Book Value per Share|Book Value per Share onconetix.gcs-web.com (ONCO)|OpGen (OPGN) - Accounting Value per Share